SHANK2 and central nervous system cancer: No published evidence was available as to the roles of the remaining eight underexpressed gene signatures (CHST9, CSDC2, ENHO, FERMT1, IGFN1, LINC00836, MGAT4C and SHANK2) regarding glioma pathogenesis or prognosis.